Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Speaking of…. Let’s revisit that millionaires list now.
Who here WAS a millionaire.
It’s a perfect counter to BIIB 10 year trial.
??We can do what you can do, we can do it better….we can do anything better than you??
Funny thing about AVXL. It is no longer PR happy. When something is relevant to the science/co, it will announce something then crouch back into its comfortable spot.
Now, we are in that comfortable spot waiting for the next relevant scientific/co announcement.
And it’s not so bad…..sure beats us being in the $5 range waiting for anything relevant.
Others may be momentarily above us price wise, but we shall see who comes out scientifically. THAT, wins the war!!
Wouldn’t it be better for the body to make vs rely on it being introduced?
In other words….. a low guess. I’ll raise your 25 and add 50% more.
Reason? mRNA from within the body vs introduced
You see BIIB pull their paper from Jama because they demanded edits be made?
“Biogen pulled Aduhelm paper after JAMA demanded edits”
Poor guys can’t even get that FIIB peer reviewed correctly
https://www.yahoo.com/news/biogen-pulled-aduhelm-paper-jama-163654140.html
It’s like watching kindergarteners paint.
I guess you want the summary to be SAVA is best cause it was the most recommended?
One day we will look back and say see, the cramers and Adams of the world really were puppets. Until then…..
We know why they NEVER mention Anavex
Unless they plan to…
I’ll bet against your hedge.
If A-273 is already approved for Rett and possibly PDD with no serious side effects among all trials…,.
Didn’t Missling attend a conference about basket trials/master protocols?
A Basket Trial involves a single investigational drug or drug combination that is studied across multiple
cancer populations defined by disease stage, histology, number of prior therapies, genetic or other
biomarkers, or demographic characteristics. It is usually designed as a single-arm, activity-estimating
trial with overall response rate as the primary endpoint. A strong response signal seen in a sub-study
may allow for expansion to generate data that could potentially support a marketing approval.
https://www.fda.gov/media/125556/download
As much as we’d all hope, I doubt it. The goal is either of the following:
1. Frustrate retail and drive them out of the stock.
2. Have retail sell for minimal gains before the real spike starts.
Fortunately, time is on our side as we know the clock has already started counting down.
Alzheimer’s alone gets us WAY pass $110
Oh no…..according to a 6 question quiz, I need to talk to my local Alzheimer’s Dr. about getting screened. I may be in the beginning stages of Alzheimer’s……
That 6 question quiz brought to you by non other than the people that will offer you a 56k fake treatment.
https://www.itstimeweknow.com/en_us/home/what-is-mild-cognitive.html
Yes. They are the perfect example of a law being a slap on the wrist. What’s 5,10,15% of your profit paying for a fine.
That sure teaches them to never do it again.
Sure, I’m so angry that I’m still up over 800%……
I’m so angry I think I’ll hold for another couple years.
Seems like when there’s nothing else to discuss, patent becomes an issue, only to not become one a week or two later.
This must be the 3rd time it has been attempted. Good ol Plato…..what ever happened to that guy….
If anyone gets down on where the current SP is, all one has to do is look at the July Anavex presentation and realize where this stock could potentially go. Doesn’t matter if the current pps don’t reflect the explosiveness it could have. As long as things are progressing, the SP will take care of itself in due time.
https://www.anavex.com/wp-content/uploads/2021/07/Anavex-Presentation-July-2021.pdf
Like I mention all the time.
Buckle up because your shares are what they want…and for as cheap as they can get em.
That’s not the way trials work. You don’t get to collect while it’s still running.
Data seems to only temporarily give pps a boost.
Parkinson’s never before seen improvement in a p2 and we here still barely holding on to 20’s.
Only catalyst Im curious about is when the dominos will start falling, putting Anavex into daily household conversations.
It’s pretty funny, not funny, when the FDA gives breakthrough therapy to another failed Amyloid thesis.
We can already guess how AAIC will be just by looking at those sponsors
Darn you falconer…always making me think I need to accumulate more shares for the long haul.
56k/yr plus added patient costs for literally no benefit vs $5 - $10 / day for yet to be seen, but already more beneficial than what $56k buys is a no brainer for ALL involved.
Hmm. As a test I should try and add, as a anonymous source of course, that Baker Bros bought those shares from them. 2.3M shares. ??
Come on, you can’t believe that. Any other company releasing results exactly the same would result in a major pps rise.
SP average some multiples lower, I don’t care where it is now, 3 months from now, or Jan 1st. I just love seeing positive upon positive data/pr release. 6 years straight and counting.
I don’t believe a p3 will be needed. There’s a difference, very large difference, between what that trial showed and what Anavex will hopefully show.
Two major hospitals said they won’t administer Biogen’s drug to treat Alzheimer’s disease, yet another blow to the pharmaceutical maker amid a debate about the drug’s effectiveness and whether regulators lowered their standards in approving it
https://www.barrons.com/articles/biogen-alzheimers-drug-51626438223?siteid=yhoof2
What to make of Missling calling A-273 a fire truck putting out fires and this article the Dr gives an example of fires as well
What would it be worth to present say P2 results for Rett, and show on a graph how they, placebo group, were doing during the blinded trial. Then include the OLE which “should” show a reversing or stopping of decline.
Sounds like a pretty powerful picture and you know what they say about a picture right….?
Hmmm, having a “pill” do much more than what BP and their blood infusion does…… yea, that’s a magic bean in my book.
Remember that post like it was yesterday. The doldrum years.
We’ve come a long ways since then haven’t we.
I’m reminded of an infomercial when Blarcamesine is approved for multiple indications.
We can do what those “other guys” try to do, but multiple times better, at 1/4 the cost.
But wait, there’s more……Not only will we help with Alzheimer’s , Parkinson’s, and so on and so forth. You’ll sleep better, do things you’ve never done in a while.Most of all, you’ll be yourself again!
I like your thoughts.
Mankind will never have known about Blarcamesine if worse case scenario were to happen. Direct offerings like the one last month is a great start. More of the same would bode well for Anavex.
BP is a greedy SOB and sometimes even the unthinkable happens all in the name of the Almighty $.
Nice to see a familiar face in the crowd.
Took a shot at CVM simply on the fact that Adam.F tweeted negative about the co.
Plus $2k doesn’t buy as much AVXL as it used to.
Now it’s time to do a little DD to see if continuing to add on the current position is a good idea.
Darn options expiration day
Biogen to come under federal probe; pressures other developers in Alzheimer’s space
Seekingalpha
https://www.google.com/amp/s/seekingalpha.com/amp/news/3714070-biogen-to-come-under-federal-probe-pressures-other-developers-in-alzheimers-space
Getting the MC above 1B was a struggle. Look at the little AVXL train about to break 2B MC.
So much more potential it’s ludicrous
Sounds more like when the losing team acknowledges the other team to be better on said particular day.
He is no hero of mine. So consider me out of the “we”.
One of them did interest me to look at CVM though
Common sense. Yes, time is in our favor. We all know the possibilities in the coming 12 months in MANY indications, not just a 1 trick pony.
Tutes can accumulate, but we don’t have enough available at these ridiculous low prices.
MM can lull but we know better. Eventually, up we go.
I like this amyloid quote:
“Even if amyloid does cause Alzheimer’s disease, it does not necessarily mean you can cure the disease by removing it,” Vanderbilt’s Schrag said. “If someone came to the emergency room with a stab wound, just removing the knife wouldn’t cure them either.”
CONTROVERSIAL NEW DRUG REIGNITES DEBATE OVER CAUSE OF ALZHEIMERS
https://apple.news/AFW4TegAmQGqetkaQvSwmVw
Yep, ANOTHER article on the mess The FDA made with “approval”
Looks like the FDA got a pickle of their making to deal with.
https://www.yahoo.com/finance/news/lundbeck-licenses-flopped-alzheimers-drug-155259016.html
So much failed Alzheimer’s trials being brought back from the dead.
Welp, here’s to Blarcamesine breaking that mouse > human Alzheimer’s barrier as well.
I enjoy reading your not always sugar coated perspective.